RWE announces the signing of a Renewable Power Purchase Agreement (PPA) in France with the French pharmaceutical group Sanofi. This 20-year contract, which became effective in early 2025, covers 21 GWh per year. The electricity will be generated by the three turbines of the “Chemin de Châlons 1” wind farm in the Marne region, with a total capacity of 9 MW.
Olaf Lubenow, Head of Commodity Solutions UK, North and South Europe: “A 20-year contract represents a long-term commitment and is a testament to the mutual trust between the signatories. This PPA highlights the relevance and competitiveness of renewable energy, particularly onshore wind, in supporting the growth and decarbonization of French industry without relying on state subsidies.”
This contract reflects the growing trend among industrial groups to decarbonize their operations, with Power Purchase Agreements (PPAs) playing a key role in this shift. PPAs have become increasingly popular as they provide companies with the dual benefits of securing stable electricity prices and advancing their energy transition objectives. With numerous agreements signed with major companies in the fields of solar energy, onshore wind energy and offshore wind energy, RWE has established itself as a leader in this field.